PHS
PFM Health Sciences’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
+12,821
| New | +$1.61M | 0.14% | 51 |
|
|
2025
Q1 | – | Sell |
-166,803
| Closed | -$22.8M | – | 78 |
|
|
2024
Q4 | $22.8M | Buy |
+166,803
| New | +$22.8M | 1.41% | 17 |
|
|
2022
Q1 | – | Sell |
-394,058
| Closed | -$33.6M | – | 72 |
|
|
2021
Q4 | $33.6M | Sell |
394,058
-470,021
| -54% | -$40M | 1.14% | 39 |
|
|
2021
Q3 | $82.9M | Sell |
864,079
-251,925
| -23% | -$24.2M | 2.44% | 13 |
|
|
2021
Q2 | $109M | Buy |
1,116,004
+60,494
| +6% | +$5.89M | 3.4% | 5 |
|
|
2021
Q1 | $103M | Buy |
+1,055,510
| New | +$103M | 3.13% | 4 |
|